Certior Financial Group’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$396K Buy
2,451
+92
+4% +$15.3K 0.21% 85
2026
Q2
$447K Buy
+2,359
New +$444K 0.25% 83

Other funds holding AZN

Certior Financial Group's AZN Position: Q3 2026 in Review

Certior Financial Group increased its AstraZeneca (AZN) stake by 3.9% in Q3 2026, buying an estimated $15.3K and bringing the position to 2,451 shares worth $396K. The position accounts for 0.21% of the portfolio, ranked #85.

Certior Financial Group first reported a position in AZN in Q2 2026 and has held it in 2 quarters since. The position peaked at $447K in Q2 2026. 1,446 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Certior Financial Group held 2,451 shares of AstraZeneca worth $396K as of Q3 2026.
  • Certior Financial Group bought 92 AstraZeneca shares in Q3 2026, an estimated $15.3K.
  • AstraZeneca made up 0.21% of Certior Financial Group's portfolio in Q3 2026, its #85 holding.
  • Certior Financial Group first reported a position in AstraZeneca in Q2 2026 and has held it in 2 quarters since.
  • Certior Financial Group's AstraZeneca position peaked at $447K in Q2 2026.
  • 1,446 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Certior Financial Group's 13F filing for Q3 2026, filed 19 Oct 2026.